Company Filing History:
Years Active: 2011
Title: **The Innovative Contributions of Christopher Jon Nulf**
Introduction
Christopher Jon Nulf is a notable inventor based in Berkeley, California, recognized for his significant contributions to biotechnology. With a focus on methods for detecting polynucleotides, he has made strides in the field that have implications for various applications, including diagnostics and research.
Latest Patents
Nulf holds one patent titled "Methods and compositions for detecting polynucleotides." This invention outlines a method for determining the presence or quantity of a target polynucleotide in a sample. The procedure involves combining a sample containing the target polynucleotide with a complementary polynucleotide, which may include nucleic acid analogs, and a dye that exhibits a change in optical properties in relation to the presence of the polynucleotide/polynucleotide hybrid. By comparing the dye's optical property changes in the reaction mixture to a reference value from a known sample, the method allows for the relative quantification of the target polynucleotide in the original sample. This innovation enhances the accuracy and reliability of polynucleotide detection.
Career Highlights
Christopher Nulf is currently associated with Investigen, Inc., where he applies his expertise in molecular biology and biotechnology to develop advanced detection methods. His work reflects a commitment to innovation and improvement in scientific research tools.
Collaborations
Throughout his career, Nulf has collaborated with esteemed colleagues, including Charles Robert Bupp II and K Yeon Choi. These partnerships have fostered a collaborative environment focused on achieving breakthroughs in polynucleotide detection and other related fields of biotechnology.
Conclusion
Christopher Jon Nulf's contributions as an inventor and researcher illustrate the importance of innovation in the field of biotechnology. His patent for methods of detecting polynucleotides not only showcases his technical acumen but also holds promise for further advancements in health diagnostics and scientific research. With continued collaboration and dedication, Nulf is poised to make even greater impacts in his field.